As is the case every year, publication of CMS’ Notice of Proposed Rulemaking was eagerly anticipated by salivating policy wonks (mea culpa), anxious hospital managers and the people who sell to them. Add the current national economic crisis, with its impacts on capital availability and revenues, and the stakes seemed especially high this year. A major Medicare hospital reimbursement squeeze could have a chilling effect on overall hospital margins and purchasing power, and a consequent effect throughout the life sciences — diagnostics, therapeutic devices, hospital supplies and equipment.
Reimbursement
Is “Obama style” healthcare reform real?
Congress last week approved President Barack Obama’s budget, and in doing so eased the path for passage of healthcare reform, one of his administration’s principal domestic initiatives. The Senate Finance Committee is getting down to the hard work of actually writing the healthcare reform bill that will, possibly by early summer, be the focal document for debate on the issue. Building on a series of roundtable discussions with key stakeholders and months of concentrated staff effort, the committee met in executive session April 29 to begin the process of selecting among alternative ideas.
Jumping the gun?
President Barack Obama’s healthcare reform effort is, at least so far, characterized by a focus on an inclusionary process aimed at consensus building. The private sector organizations that have the knowledge and experience to understand healthcare system problems and inefficiencies, and that will need to be involved in implementing solutions, are being engaged and heard (PDF) by those who are crafting the detailed legislative proposals we’ll be talking about and debating later this year. It is — at least so far — all very civilized and high-minded, and hard to criticize.
Medicare eases PET scan coverage rules
On April 3, the Centers for Medicare & Medicaid Services published a decision memorandum announcing significant easing of its coverage requirements for Positron Emission Tomography (PET) testing of solid tumors and myeloma. A minimally invasive diagnostic imaging procedure, PET uses a radioactive tracers to evaluate glucose metabolism in tumors and in normal tissue.